Trade with Congress

SUPNSUPNSupernus Pharmaceuticals, Inc

2 members of Congress disclosed 9 transactions in SUPN between May 28, 2020 and Mar 3, 2026.

Price, with congressional trades marked

57.044.231.4Jul 2025SepNovJan 2026MarMayJul
SUPN $47.62latest
-4%Gilbert Ray Cisneros, Jr., Democrat
+2%Gilbert Ray Cisneros, Jr., Democrat
-13%Gilbert Ray Cisneros, Jr., Democrat
Jul 7, 2025 – Aug 7, 2026 · closing price, dividend and split adjusted▲ buy · ▼ sell · % is the price change since that trade, not benchmark-adjusted
Marked trades (3)
TradedMemberAmountAdj. closeSUPN sinceSPY sinceDifference
Oct 9, 2025Gilbert Ray Cisneros, Jr. (D)sell~$8K$49.52-3.8%+16.2%-20.0%
Dec 11, 2025Gilbert Ray Cisneros, Jr. (D)buy~$8K$46.51+2.4%+13.1%-10.7%
Mar 3, 2026Gilbert Ray Cisneros, Jr. (D)buy~$8K$54.55-12.7%+14.3%-27.0%

Prices are dividend- and split-adjusted, so “adj. close” is not necessarily what the stock printed that day. The horizon runs to the latest close, so rows with different trade dates are not comparable to each other — and none of these is the benchmark-relative, fixed-window alpha the leaderboard ranks on.

9
Transactions
7 buys · 2 sells
2
Members
$72K
Est. volume
2D / 0R
Party split
distinct members

Who traded it

MemberTradesBuys / SellsEst. volume
Gilbert Ray Cisneros, Jr.D-CA76 / 1~$56K
Josh GottheimerD-NJ21 / 1~$16K

Transactions

9
MemberTypeAmountTradedDisclosedSource
Buy$1K – $15KMar 3, 2026Apr 7, 2026
35d
filing
Buy$1K – $15KDec 11, 2025Jan 12, 2026
32d
filing
Sell (part)$1K – $15KOct 9, 2025Nov 18, 2025
40d
filing
Buy$1K – $15KMar 24, 2025Apr 7, 2025
14d
filing
Sell (part)joint$1K – $15KDec 23, 2022Jan 13, 2023
21d
filing
Buy$1K – $15KNov 13, 2020Dec 15, 2020
32d
filing
Buy$1K – $15KJul 17, 2020Aug 19, 2020
33d
filing
Buy$1K – $15KJun 1, 2020Jun 16, 2020
15d
filing
Buyjoint$1K – $15KMay 28, 2020Jun 10, 2020
13d
filing

Disclosures are filed up to 45 days after a trade, so this is a record rather than a signal. Amounts are bracket midpoints. Symbols are recorded as they existed on the trade date and mapped forward where a company was renamed.